Investing In Becton Dickinson & Co. (NYSE: BDX): Why Should You?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed New Survey Reveals Patients Receive Too Many Needlesticks.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

The company is listed on the NYSE and operates within the Medical Instruments & Supplies industry segment. The current market capitalization of Becton Dickinson & Co. is $70.37B. A total of 1.22 million shares were traded on the day, compared to an average of 1.45M shares.

In the most recent transaction, Spoerel Thomas J sold 282 shares of BDX for 238.29 per share on Mar 14 ’24. After the transaction, the SVP,Controller&Chief Acct Off now owns 2,276 company shares. In a previous transaction on Dec 11 ’23, Garrison Michael David sold 1,239 shares at 232.46 per share. BDX shares that EVP & President Medical owns now total 7,274.

Among the insiders who sold shares, Byrd Richard disposed of 2,156 shares on Nov 28 ’23 at a per-share price of $238.47. This resulted in the EVP & President Interventional holding 4,120 shares of BDX after the transaction. In another insider transaction, Byrd Richard sold 459 shares at $274.48 per share on Sep 05 ’23. Company shares held by the EVP & President Interventional now total 3,444.

Dividend

The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Becton Dickinson & Co. pays an annual dividend of $3.72, resulting in a dividend yield of 1.53%, and it has a price to earnings (P/E) ratio of 57.61. BDX’s most recent ex-dividend date was 3/7/2024 when it declared a $0.95 quarterly dividend that was paid in cash on 3/29/2024. Previously, the company paid the dividend on 12/29/2023 with an ex-dividend date of 12/7/2023. The BDX stock dividend was $0.95 per share in cash.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, BDX has a high of $287.32 and a low of $229.85.

As of this writing, BDX has an earnings estimate of $2.96 per share for the current quarter. EPS was calculated based on a consensus of 12 estimates, with a high estimate of $2.99 per share and a lower estimate of $2.92. The company reported an EPS of $3.42 in the last quarter, which was -0.30% lower than expectations of $3.43.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BDX’s latest balance sheet shows that the firm has $2.29B in Cash & Short Term Investments as of fiscal 2021. There were $17.61B in debt and $6.63B in liabilities at the time. Its Book Value Per Share was $87.68, while its Total Shareholder’s Equity was $23.68B.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BDX is Buy with a score of 4.53.

Most Popular

Related Posts